Altimmune, Inc. — Director's Dealing 2010

Jun 1, 2010

SEC Form 4/A — Form 4/A

Issuer: PHARMATHENE, INC (PIP)
CIK: 0001326190
Period of Report: 2010-05-26

Reporting Person: PAPPAJOHN JOHN (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2010-05-26	Common Stock, $0.0001 par value per share	P	54344	$1.4881	Acquired	865508	Direct
2010-05-27	Common Stock, $0.0001 par value per share	P	45656	$1.5099	Acquired	911164	Direct

Footnotes

F1: This amendment includes additional pricing information in footnotes (1) and (2) that was unavailable at the time of the
original filing on May 28, 2010. The price reported in Column 4 is a weighted average price. These shares were purchased in
multiple transactions at prices ranging from $1.47 to $1.50 per share. The reporting person undertakes to provide to
PharmAthene, Inc., any security holder of PharmAthene, Inc., or the staff of the Securities and Exchange Commission, upon
request, full information regarding the number of shares purchased by him at each separate price on May 26 and May 27, 2010.

F2: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices
ranging from $1.50 to $1.51 per share.